Caring Brands, Inc. (CABR) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated September 11, 2026, details the completion of a subsequent closing under a private placement Securities Purchase Agreement and provides preliminary pro forma financial information to address a Nasdaq listing deficiency. The filing addresses the Company's efforts to regain compliance with Nasdaq Listing Rule 5550(b)(1) regarding the Stockholders' Equity Requirement.
Key Financial Metrics and Capital Raise
- Subsequent Closing Proceeds: On September 11, 2026, the Company raised $2,549,900 in gross proceeds.
- Securities Issued (Subsequent Closing): 2,549.9 shares of Series B Convertible Preferred Stock, Series A Warrants to purchase up to 2,549,900 shares of Common Stock, and Series B Warrants to purchase up to 2,549,900 shares of Common Stock.
- Total Offering Proceeds: Following this closing, the aggregate gross proceeds from the Offering total $7,149,900.
- Total Securities Issued (Offering to Date): 7,149.9 shares of Series B Preferred Stock and warrants to purchase up to 7,149,900 shares of Common Stock for each warrant series.
- Preliminary Pro Forma Equity: As of August 31, 2026, the preliminary unaudited pro forma stockholders' equity is $8,220,419.
- Historical Equity Deficiency: The Company's Form 10-K for the year ended December 31, 2025, reported stockholders' equity of $2,091,324, which was below the $2,500,000 Nasdaq requirement.
Material Changes and Listing Status
The primary material change is the increase in stockholders' equity resulting from the private placement, intended to resolve a delisting determination issued by Nasdaq on July 15, 2026. The Company had previously been notified on April 7, 2026, of non-compliance with the Stockholders' Equity Requirement. The pro forma information indicates the Company now exceeds the $2,500,000 threshold. However, the filing notes that subscription documents for an additional $4,400,000 were executed as of September 1, 2026, but no assurance is given that these funds will be released or that additional closings will occur.
Outlook, Risks, and Management Commentary
- Nasdaq Compliance: The Company intends to submit this report to the Nasdaq Hearings Panel to request a determination that it has regained compliance. There is no assurance that the Panel will confirm compliance or that delisting proceedings will be terminated.
- Financial Statement Caveats: The pro forma information is preliminary and unaudited. Final reported amounts may differ materially due to adjustments in the classification and valuation of preferred stock, warrants, embedded features, offering costs, and accrued liabilities.
- Future Risks: Risks include the potential for further operating losses, preferred dividends, or other charges that could reduce stockholders' equity below the required threshold. The Company also faces risks regarding the accounting treatment of the securities and the ability to satisfy other listing standards.
- Next Reporting Period: The Company's next periodic report will be the Form 10-Q for the quarter ending September 30, 2026.
Investor Verification Checklist
- Verify the final determination by the Nasdaq Hearings Panel regarding the Company's compliance with the Stockholders' Equity Requirement.
- Review the audited financial statements in the upcoming Form 10-Q to confirm the final stockholders' equity figure and any adjustments to the preliminary pro forma data.
- Monitor the status of the remaining $4,400,000 in executed subscription documents to determine if additional capital will be raised.
- Assess the dilution impact of the 7,149,900 Series A Warrants and 7,149,900 Series B Warrants upon exercise.
- Confirm the final accounting treatment of the Series B Preferred Stock and associated warrants, as preliminary valuations may change.